← All trials
NCT03773536
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 9, 2017
- Primary completion
- Sep 25, 2017
- Completion date
- Sep 25, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 146
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Karolinska InstituteLead sponsor
- Government of ZanzibarCollaborator
- Karolinska InstituteSponsor investigator
- Uppsala UniversityCollaborator
- Uppsala UniversityStudy chair
- Zanzibar Malaria Elimination ProgrammeCollaborator
- Zanzibar Malaria Elimination ProgrammeStudy director
- Government of ZanzibarOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.